Aquarius Surgical Technologies Inc.
AQQRF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 10.6% | 20.9% | -64.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 54.3% | 60.9% | 47.8% | 52.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -487.5% | -519.2% | -1,404.7% | -359.3% |
| Other Income/Exp. Net | $1 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $1 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | -$0 | -$0 | -$0 |
| % Margin | 4,039.9% | -3,023.9% | -1,845.2% | -586.5% |
| EPS | 0.03 | -0.018 | -0.009 | -0.008 |
| % Growth | 271.4% | -98.9% | -10% | – |
| EPS Diluted | 0.03 | -0.018 | -0.009 | -0.008 |
| Weighted Avg Shares Out | 28 | 28 | 28 | 28 |
| Weighted Avg Shares Out Dil | 28 | 28 | 28 | 28 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | -$0 | -$0 | -$0 |
| % Margin | 4,642% | -2,524% | -1,197.4% | -350.7% |